A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up
2012 ◽
Vol 47
(11)
◽
pp. 1448-1454
◽
2018 ◽
Vol 24
(3)
◽
pp. S251-S252
2018 ◽
Vol 7
(4)
◽
pp. 132-137
◽
2016 ◽
Vol 22
(3)
◽
pp. S189
2021 ◽
Vol 10
(2)
◽
pp. 113-117
2009 ◽
Vol 15
(2)
◽
pp. 72-73
2008 ◽
Vol 14
(9)
◽
pp. 1017-1021
◽
2013 ◽
Vol 48
(12)
◽
pp. 1578-1580
◽
2015 ◽
Vol 90
(7)
◽
pp. E133-E134
◽